Ageing is the greatest risk factor for many pathological conditions including cancers, neurodegenerative disorders, cardiovascular diseases, and diabetes 1 . Physiological ageing is a complex and multifactorial process that is regulated by both genetic and environmental factors 2 . Although tissues across the body are seemingly affected in different ways, one emerging hallmark of ageing is that reduction in tissue function usually correlates with a reduction in stem cell activity 3 . The blood system is critical for many aspects of organismal health, and proper maintenance of blood production relies on the ability of haematopoietic stem cells (HSCs) to self-renew and differentiate into all lineages of mature blood cells 4 . In adults, HSCs are rare and reside in specialized niches in the bone marrow cavity, where they are kept in a low metabolic, mainly glycolytic, quiescent state unless called upon to regenerate the blood system 5 . With age, HSCs lose their regenerative abilities, but their overall expansion maintains blood production in old organisms, albeit with typical features of blood ageing such as anaemia, immunosenescence, increased production of myeloid cells, and higher predisposition to haematological cancers 6 . Yet, how old HSCs (oHSCs) retain some functional abilities in an adverse ageing bone marrow microenvironment 7,8 remains largely unknown. Macroautophagy (hereafter called autophagy) is an essential proteostasis and stress response mechanism that maintains cellular health by regulating the quantity and quality of organelles and macromolecules through lysosomal degradation, which is activated in response to nutrient deprivation and other stressors to generate energy and allow survival 9 . Autophagy is controlled by a series of autophagy-related genes (Atg) such as the ATG12 conjugation system (Atg12-Atg5-Atg16) that are essential for the formation of double-membrane autophagosomes. Autophagy is regulated by important nutrient-sensing pathways including the mechanistic target of rapamycin (mTOR) and 5′ AMPactivated protein kinase (AMPK), which inhibits and activates autophagy, respectively. Autophagy is critical for the proper development of the blood system 10,11 , for HSC mobilization 12 , and to allow adult HSCs to survive acute metabolic stress 13 . Autophagy declines with age in many tissues 14 , and reduced autophagy levels in muscle stem cells directly contribute to decreased regenerative potential and muscle atrophy 15 . In contrast, we previously found increased basal autophagy in oHSCs 13 . Here, we set out to identify how autophagy controls HSC function, and how changes in autophagy levels affect HSC ageing.
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Ageing phenotypes upon loss of autophagy
To inactivate autophagy in adult HSCs, we used our previously described Atg12 flox/flox :Mx1-Cre conditional knockout (Atg12 cKO ) mouse model 13 , and deleted Atg12 with poly(I:C) (pIC) at 4 weeks of age (Fig. 1a) . Surprisingly, the blood system of Atg12 cKO mice remained largely healthy, with no persisting anaemia or lymphopenia observed over time as reported in other contexts 10, 11, 16 (Extended Data Fig. 1a ). Atg12 cKO mice showed increased cellularity in the peripheral blood and spleen, and, similar to autophagy inactivation in fetal HSCs 11 , had a skewed ratio of circulating myeloid versus lymphoid cells, thus resembling the myeloid-bias observed in old mice ( To investigate the regenerative capacity of Atg12 cKO HSCs, we first performed classic transplantation experiments with purified HSCs to directly measure their self-renewal and multilineage reconstitution activity (Extended Data Fig. 2f ). Transplantation of 250 Atg12
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These features were further exacerbated upon secondary transplantation of 500 re-isolated Atg12 cKO HSCs, and directly demonstrated defective self-renewal activity in autophagy-deficient HSCs that closely resembled the functional impairment of oHSCs (Extended Data Fig. 2g ). To address whether the need for autophagy changed with age, we next transplanted 2 × 10 6 bone marrow cells from non-pIC-treated animals into lethally irradiated mice, induced Atg12 deletion 2 months after transplantation, and followed the recipients for up to 16 months after pIC treatment (Extended Data Fig. 2h ). Of note, Atg12 cKO mice could not be aged past 8 months after pIC owing to hepatomegaly from off-target deletion in the liver. Importantly, haematopoietic-specific deletion of Atg12 in transplanted mice led to a progressive age-related decline in donor-chimaerism and myeloid-biased lineage distribution (Fig. 1d) , thus confirming the cell-intrinsic nature of these defects. These ageing features were further exacerbated upon deletion of autophagy in mice transplanted with bone marrow cells from 24-monthold animals (Extended Data Fig. 2i ). Collectively, these results indicate striking similarities between autophagy-deficient HSCs and oHSCs with defective self-renewal activity and myeloid-biased differentiation potential, and demonstrate that autophagy is most critical for HSC function during ageing and in conditions of intense regenerative stress such as transplantation.
Autophagy regulates HSC metabolism
We next investigated how loss of autophagy affects HSC function. Electron microscopy analyses revealed increased numbers of total and elongated, fused mitochondria in Atg12 cKO HSCs, which was directly confirmed by immunofluorescence staining for the mitochondrial protein TOM20 and flow cytometry measurements of mitochondrial mass with Mitotracker Green (MTG) (Fig. 2a-c and Extended Data  Fig. 3a) . Atg12 cKO HSCs also had expanded endoplasmic reticulum (ER) and Golgi compartments, and increased numbers of small vesicles and lysosomes, confirmed by immunofluorescence staining and flow cytometry dye measurements (Extended Data Fig. 3b-e) . These cellular features, together with elevated levels of p62 (Extended Data Fig. 3f ), confirmed the loss of bulk autophagy in Atg12 cKO HSCs, and suggest activation of alternative mechanisms of cellular recycling 17 to allow HSC maintenance at steady state. Autophagy is known to degrade mitochondria through several pathways including the PINK1/PARK2 stress mitophagy pathway 18 , which specifically clears damaged mitochondria. HSCs from Park2 −/− mice 19 showed decreased levels of mitochondrial membrane potential dye tetramethylrhodamineethyl-ester (TMRE), and TMRE/MTG ratio, probably reflecting damaged mitochondria (Extended Data Fig. 3g ). In contrast, Atg12 cKO HSCs had increased TMRE levels and TMRE/MTG ratio, indicating more active mitochondria (Fig. 2d, e) . Further characterization of Park2 −/− mice also revealed no similarities to the phenotypes of Atg12 cKO mice, and normal function of Park2 −/− HSCs in transplantation experiments (Extended Data Fig. 3h-n) . These results indicate that autophagy is most important for the clearance of healthy, active mitochondria in HSCs, as opposed to stress-induced specific removal of damaged mitochondria via mitophagy as recently studied 20, 21 . To understand the link between autophagy regulation and mitochondrial activity, we next grew wild-type HSCs or HSCs isolated from autophagy-reporter Gfp-Lc3 mice 22 in cytokine-rich (+ cyt) conditions to force them out of quiescence and investigate their activated state before their first cell division (Fig. 2f) . As expected, mTOR was rapidly activated in + cyt conditions, whereas it remained (g) pS6 levels measured by flow cytometry (results are normalized to immunoglobulin-G (IgG) levels); (h) pS6, total S6, and pAMPK levels measured by western blot (actin was used as loading control); (i) GFP-LC3 levels (n = 6 for 0 h; ± s.e.m.); and (j) mitochondrial parameters (n = 6 (TMRE), 10 (forward scatter, FSC), 7 (NADH), 4 (2-NBDG), and 7 (MTG) at 0 h; ± s.e.m.). Data are mean ± s.d. except when indicated, and are expressed relative to control HSC (a-e) or 0 h HSC (g, i, j) levels. * P ≤ 0.05, * * P ≤ 0.01, * * * P ≤ 0.001.
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inactive in cytokine-starved (− cyt) conditions, while AMPK was transiently induced (Fig. 2g, h and Extended Data Fig. 4a ). This was accompanied by a rapid reduction of GFP-LC3 levels reflecting autophagy activation in -cyt conditions, and increased GFP-LC3 and p62 levels indicating autophagy inhibition in + cyt conditions ( Fig. 2i and Extended Data Fig. 4b, c) . Furthermore, pharmacological mTOR inhibition or AMPK activation directly induced autophagy in Gfp-Lc3 HSCs grown in + cyt conditions, while AMPK inhibition reduced autophagy induction in − cyt conditions (Extended Data  Fig. 4d ). In + cyt conditions, we also found a steady increase in mitochondrial mass and membrane potential, reflecting mitochondrial activation, and cell size, NADH levels and glucose uptake, suggesting increased metabolic activity (Fig. 2j) . Seahorse metabolic flux analyses measuring oxygen consumption rates confirmed markedly increased oxidative phosphorylation (OXPHOS) levels in activated HSCs (aHSCs) grown for 21 h in + cyt conditions compared with freshly isolated, quiescent HSCs (qHSCs) (Fig. 3a) . Collectively, these results demonstrate that qHSCs switch from a normally low OXPHOS state to a high mitochondria-driven OXPHOS state during activation.
Strikingly, Atg12 cKO HSCs also exhibited these features of an aHSC state, with increased cell size, NADH, ATP, and glucose uptake (Fig. 3b, c and Extended Data Fig. 4e ). Furthermore, freshly isolated HSC-enriched Atg12 cKO LSK cells (Lin − /c-Kit + /Sca-1 + ) displayed increased OXPHOS levels, specifically maximum capacity, with unchanged glycolysis levels measured by extracellular acidification rate ( Fig. 3d and Extended Data Fig. 4f ). Similar to Atg12 cKO LSKs, oHSCs also exhibited increased cell size, NADH and ATP levels, and elevated OXPHOS with decreased glycolysis (Fig. 3c , e and Extended Data Fig. 4e, g ), suggesting an overactive oxidative metabolism. However, in contrast to Atg12 cKO HSCs, oHSCs had decreased TMRE levels and TMRE/MTG ratios (Extended Data Fig. 4h ), which could indicate the presence of some damaged mitochondria 23 . Collectively, these results demonstrate that HSC activation is directly associated with metabolic activation and increased mitochondrial OXPHOS, and that, in the absence of autophagy, HSCs are kept in an activated state reminiscent of the alert state recently described for muscle stem cells 24 . They also show that oHSCs, like autophagy-deficient HSCs, are metabolically more active than young HSCs (yHSC).
Loss of autophagy alters HSC fate
We then explored the consequences of increased oxidative metabolism for Atg12 cKO HSC fate decisions. Similar to aHSCs, Atg12 cKO HSCs showed increased levels of reactive oxygen species (ROS), which did not cause DNA damage or apoptosis (Extended Data Figs 4i-k and 5a). As expected for more metabolically activated cells, Atg12 cKO HSCs also had elevated protein synthesis rates and increased cell cycle activity (Extended Data Fig. 5b, c) . Notably, oHSCs showed reduced ROS levels and decreased protein synthesis rates, which contrasted with their OXPHOS-activated status, but is probably influenced by their replication stress features 25 (Extended Data Fig. 5d , e). However, both Atg12 cKO HSCs and oHSCs 25 displayed a similar loss of quiescence and pro-myeloid differentiation associated with increased unipotent mature colonies and decreased multipotent immature colonies formed in methylcellulose (Fig. 4a, b) . Strikingly, yHSCs treated with the autophagy inhibitor bafilomycin A (BafA) and untreated oHSCs showed a matching reduction in multipotent colonies, which was greatly exacerbated in BafA-treated oHSCs (Fig. 4c) . Interestingly, treatment with the antioxidant N-acetylcysteine (NAC), which is known to ameliorate many ROS-mediated phenotypes 26 , did not rescue the precocious myeloid differentiation of Atg12 cKO HSCs in methylcellulose, nor limit the myeloid expansion in Atg12 cKO mice treated in vivo (Extended Data Fig. 5f-i ). These data demonstrate that the non-cytotoxic increase in ROS levels observed in metabolically activated Atg12 cKO HSCs has no major role in driving precocious myeloid differentiation in 
Loss of autophagy perturbs HSC epigenetic poising
To gain a better understanding of the mechanisms affected by the loss of autophagy, we performed gene expression microarray analyses on HSCs and GMPs. While significant transcriptional differences were observed in Atg12 cKO HSCs using a P value < 0.01, surprisingly, apart from Atg12, no individual genes were significantly differentially expressed using a false discovery rate of 0.05 (Supplementary  Table 1 and Extended Data Fig. 6a, b) . However, gene set enrichment analyses revealed reduced expression of HSC-identity genes 28 and increased expression of both myeloid genes 28 and genes elevated in oHSCs 25 (Extended Data Fig. 6c )
. Complementary Fluidigm qRT-PCR analyses confirmed limited transcriptional changes in Atg12 cKO
HSCs, but also identified a small set of significantly downregulated genes that render them more similar to downstream MPPs (Fig. 4d  and Supplementary Tables 2 and 3 ). DAVID analyses also showed changes in mitochondrial and other metabolic terms in Atg12 cKO GMPs, confirming more significant gene expression alterations in progenitor cells (Extended Data Fig. 6d and Supplementary Table 1) . Since metabolism has become increasingly linked to epigenetic regulation 26 , we also performed enhanced reduced-representation bisulfite sequencing (ERRBS) analyses of DNA methylation. Strikingly, Atg12 cKO HSCs showed a significantly altered DNA methylation profile, with 162 hypermethylated and 783 hypomethylated differentially methylated regions (DMRs) (Fig. 4e) . DAVID analyses identified phosphoproteins as the most enriched class of genes in hypomethylated DMRs (Supplementary Table 4 ). Taken together, these results are consistent with the idea that changes in fate decisions observed at steady state in autophagy-deficient HSCs are the consequence of an epigenetic reprogramming that begins to alter gene expression in HSCs, with amplification of transcriptional changes in downstream progenitors.
Metabolic-driven epigenetic remodelling
To gain a better understanding of the link between metabolic activation, epigenetic reprograming and control of HSC fate decisions, we conducted a more extensive analysis of 21 h + cyt aHSCs versus freshly isolated qHSCs, and performed both ERRBS and Fluidigm qRT-PCR analyses. Strikingly, we also observed an altered DNA methylation profile, which was more restricted than in Atg12 cKO HSCs, but also mainly consisted of hypomethylation events with 38 hypomethylated and 17 hyermethylated DMRs (Fig. 4f) . Gene Ontology analyses indicated enrichment for Stat3 regulation (Supplementary Table 5 ). Moreover, we found a clear overlap between the changes in gene expression in aHSCs and Atg12 cKO HSCs, suggesting activation of similar mechanisms of fate decision (Fig. 4d and Supplementary Table 2 ). To directly test the importance of metabolic-driven epigenetic remodelling in aHSCs, we added α -ketoglutarate (α KG), a necessary co-factor for many demethylases 29 , S-adenosylmethionine (SAM), a methyl donor cosubstrate for methylases 30 , and metformin (Mtf), an inhibitor of mitochondrial complex I 31 , to differentiating HSCs grown in + cyt conditions for 3 days, and analysed lineage commitment. Strikingly, addition of α KG enhanced myeloid differentiation, while addition of SAM or Mtf preserved stemness in + cyt HSCs (Fig. 4g) . These results indicate that even in the context of strong differentiation stimuli, the epigenetic remodelling associated with metabolic activation directly affects HSC fate decisions. Finally, we measured SAM and α KG cellular levels (Extended Data Fig. 6e, f) . While only trending in Atg12 cKO HSCs, we observed a strong reduction in SAM levels in aHSCs, and found a large increase in α KG levels in both Atg12 cKO and 21 h + cyt c-Kit-enriched bone marrow cells. These results suggest that epigenetic remodelling and DNA demethylation are early consequences of increased oxidative metabolism, and play a direct role in HSC loss of stemness and accelerated myeloid differentiation. Collectively, they demonstrate an essential role for autophagy in clearing metabolically activated mitochondria and allowing HSCs to maintain a mostly glycolytic, quiescent state.
Autophagy levels define distinct subsets of oHSCs
While oHSCs share many deregulated features with Atg12 cKO HSCs, we previously reported increased basal autophagy in oHSCs 13 . To address this discrepancy and to determine its significance, we profiled GFP-LC3 expression in various haematopoietic populations of young and old Gfp-Lc3 mice as a surrogate of autophagy levels. In unfractionated bone marrow cells, mature B and T cells, and most of the progenitor populations including GMPs and MPP4, GFP-LC3 levels were increased with age, indicating an overall decrease in autophagy activity, as already reported for T cells 32 (Fig. 5a, b) . Interestingly, this corresponded to populations that were either unchanged or decreased in number in old mice (Extended Data Fig. 7a ). In contrast, expanded myeloid cells did not have altered GFP-LC3 levels, and the enlarged MPP2/3 and HSC compartments both contained subsets with decreased GFP-LC3 expression. While the average GFP-LC3 expression and overall mTOR activity did not significantly change between yHSCs and oHSCs (Extended Data Fig. 7b ), careful examination of oHSCs revealed an increase in cells with both lower and higher GFP-LC3 levels, reflecting the appearance of subsets with either high autophagy (AT hi ) or low autophagy (AT lo ), respectively (Fig. 5c) . Re-analysis of electron microscopy pictures 13 ( Fig. 5d) and measurement of autophagy with Cyto-ID dye (Extended Data Fig. 7c, d ) also indicated that approximately onethird of oHSCs had autophagosomes and activated autophagy. Thus, while most of the blood cells including most of the HSC compartment show no activation or a decline in autophagy with age, a fraction of oHSCs have increased autophagy levels.
To study the differences between AT hi and AT lo oHSCs, we isolated cells with the 33% lowest and 33% highest GFP-LC3 levels, respectively (Extended Data Fig. 7e ). This sub-fractionation revealed no changes in nuclear FoxO3a, but uncovered decreased mTOR activity specifically in AT hi oHSCs (Fig. 6a and Extended Data Fig. 7f) , thus identifying the cause for autophagy induction in this subset. By electron microscopy 
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analyses, oHSCs with autophagosomes displayed normal youthful organelle biology, while oHSCs without autophagosomes showed almost identical features to Atg12 cKO HSCs, with expanded ER, Golgi, and small vesicle compartments, and increased numbers of total and elongated mitochondria, which was confirmed by TOM20 immunofluorescence staining in AT lo oHSCs ( Fig. 6b and Extended Data Fig. 7g, h ). AT lo oHSCs also had increased cell size and elevated TMRE, NADH, ATP, glucose uptake, and ROS levels (Fig. 6c-f and Extended Data Fig. 7i-k) , remarkably similar to the overactive metabolic features of Atg12 cKO HSCs. This resulted in increased cell cycling, overproliferation in self-renewal conditions, and pro-myeloid differentiation specifically in AT lo oHSCs (Fig. 6g and Extended Data Fig. 7l, m) . Strikingly, nucleolar γ H2AX foci that are hallmarks of replication stress in oHSCs 25 were almost exclusively found in AT lo oHSCs (Fig. 6h) . In contrast, AT hi oHSCs closely resembled healthy yHSCs for all of these characteristics. Taken together, these results indicate that by preventing entry into an activated state, autophagy preserves a subset of oHSCs from replication stress and associated cellular ageing. This is actually very different from the functions of autophagy in muscle stem-cell activation 33 and prevention of senescence 15 .
Autophagy activation maintains healthier oHSCs
We next analysed the functionality of these subsets and transplanted 250 AT lo or AT hi oHSCs into lethally irradiated recipients (Extended Data Fig. 8a ). While both subsets initially engrafted at similar levels, AT lo oHSCs rapidly declined and were unable to maintain efficient long-term reconstitution and HSC numbers (Fig. 6i) . In contrast, AT hi oHSCs exhibited surprisingly robust long-term reconstitution and HSC regeneration potential. These functional differences persisted with a more restrictive 15% GFP-LC3 AT hi/lo oHSC cutoff and upon secondary transplantation, although they became attenuated, perhaps owing to normalization of autophagy levels in re-isolated oHSC subsets, potentially as a consequence of repeated exposure to a young bone marrow microenvironment (Extended Data Fig. 8b , c). They were also specific to oHSCs, as AT lo and AT hi yHSCs isolated with the same 33% GFP-LC3 cutoffs had no differences in regenerative abilities (Extended Data Fig. 8d) . Collectively, these results demonstrate that AT lo and AT hi oHSCs are functionally distinct subsets, with autophagy-activated oHSCs being the fittest aged stem cells responsible for the majority of the repopulation potential, and autophagy-inactivated oHSCs driving most of the blood ageing phenotypes. We also investigated the reversibility between AT lo and AT hi oHSC subsets. Strikingly, there were no discernible differences in CD150 expression between these two subsets, and oHSCs were almost identical to yHSCs for both mTOR activation in + cyt conditions and pharmacological modulation of autophagy levels (Extended Data Fig. 9a-c) . In fact, AT lo and AT hi oHSCs, despite initial differences in GFP-LC3 levels, were able to repress and activate autophagy to similar extents in ± cyt conditions, and upon glutamine starvation (Extended Data Fig. 9d-g ). Furthermore, both AT lo and AT hi oHSCs had equivalent autophagy flux, which was comparable to yHSCs (Extended Data  Fig. 9f ). These results demonstrate that while subsets of oHSCs with different mTOR and autophagy levels exist in vivo, they both maintain the ability to upregulate and downregulate autophagy upon strong stimulation.
Discussion
Our results demonstrate an essential function for autophagy in removing activated mitochondria and controlling oxidative metabolism, thereby maintaining HSC stemness and regenerative potential (Extended Data  Fig. 10 ). They link metabolic reprogramming with epigenetic modifications in the control of HSC fate, and establish autophagy as one of the essential gatekeepers of HSC quiescence. This role becomes even more important during ageing as the inability of the majority of oHSCs to activate autophagy in vivo results in an overactive OXPHOS metabolism that drives most of the ageing blood phenotypes, including impaired engraftment and replication stress. While all oHSCs remain competent for autophagy induction, only about one-third of them activate autophagy in the ageing bone marrow microenvironment 7, 8 , and maintain a low metabolic state with robust regeneration potential akin to yHSCs. Our findings have exciting implications for rejuvenation therapies as they identify a cellular characteristic that can be directly targeted to improve oHSC function and preserve the health of an ageing blood system. In this context, understanding why some old stem cells activate autophagy and others do not, as well as identifying the environmental drivers for this differential adaptive response, will help further our understanding of cellular ageing, and develop more targeted approaches for improving organismal health during ageing.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. :Mx1-Cre conditional knockout (cKO) mice were used 2-3 months after pIC injection, unless otherwise indicated. For deletion in transplanted mice, recipients were injected 2 months after transplantation with pIC as described above. For mouse studies, no specific randomization or blinding protocol was used, animals of both genders were used, and all experiments were performed in accordance with University of California, San Francisco (UCSF) Institutional Animal Care and Use Committee approved protocols. In vivo assays. For 5-fluorouracil (5-FU; Sigma-Aldrich) treatment, mice were injected intraperitoneally with 150 mg/kg 5-FU or vehicle (PBS) four times once a month and analysed for blood parameters by regular bleeding every 3-5 days. For in vivo starvation experiments, mice were deprived of food for 24 h with free access to water. For transplantations experiments, 8-to 12-week-old CD45.1 C57Bl/6-Boy/J recipient mice were lethally irradiated (11 Gy, delivered in split doses 3 h apart) using a 137 Cs source (J. L. Shepherd), and injected retro-orbitally with either 250-1,000 purified CD45.2 HSCs delivered together with 250,000 Sca-1-depleted helper CD45.1 bone marrow cells or just with 2 × 10 6 unfractionated CD45.2 bone marrow cells. Transplanted mice were kept on antibiotic-containing water for 4 weeks, and analysed for donor-derived chimaerism by monthly bleeding. Peripheral blood was obtained via retro-orbital bleeding, and collected in 4 ml of ACK (150 mM NH 4 Cl/10 mM KHCO 3 ) containing 10 mM EDTA for flow cytometry analyses, or in EDTA-coated tubes (Becton Dickinson) for complete blood counts. Complete blood count analyses were performed using a Hemavet haematology system (Drew Scientific). For EdU incorporation, mice were injected with 100 μ l of 1 mg/ml 5-ethynyl-2 deoxyuridine (EdU, Thermo Fisher Scientific, A00144) 3 h before being killed. For NAC treatments, mice were given water containing 1 mg/ml NAC (Sigma-Aldrich, A7250-100G) for 8 weeks starting on the day of the final pIC treatment. Flow cytometry. Haematopoietic stem and progenitor cells were analysed and/or isolated as described 36 . Bone marrow cells were obtained by crushing leg, arm, and pelvic bones (with eventually sternum and spines for some experiments) in Hanks' buffered saline solution (HBSS) containing 2% heat-inactivated FBS (staining media), and single-cell suspensions of splenocytes by mechanical dissociation between two slides of whole spleens. Erythrocytes were removed by ACK lysis, and single-cell suspensions of bone marrow cells were purified on a Ficoll gradient (Histopaque 1119, Sigma-Aldrich). Bone marrow cells were then enriched for c-Kit + cells using c-Kit microbeads (Miltenyi Biotec, 130-091-224) and an AutoMACS cell separator (Miltenyi Biotec) or MACS Separation LS Columns (Miltenyi Biotec, 130-042-401). For cell analyses, unfractionated bone marrow cells were incubated with purified rat anti-mouse lineage antibodies (CD3 from BioLegend, and CD4, CD5, CD8, B220, Ter119, Mac-1, and Gr-1 from eBioscience) followed by goat anti-rat-PE-Cy5 (Invitrogen, A10691) and subsequently blocked with purified rat IgG (Sigma-Aldrich). Cells were then stained with c-Kit-APC-eFluor780 (eBioscience, 47-1171-82), Sca-1-PB (BioLegend, 108120), CD48-A647 (BioLegend, 103416), CD150-PE (BioLegend, 115904), and Flk2-bio (eBioscience, 13-1351-82) followed by either SA-PeCy7 (eBioscience, 25-4317-82) or SA-Qdot605 (Invitrogen, Q10101MP) for HSC staining, or together with CD34-FITC (eBioscience, 11-0341-85) and Fcγ R-PerCP-eFluor710 (eBioscience, 46-0161-82) for combined HSC/myeloid progenitor staining. For Gfp-Lc3 mice analyses and dye staining requiring FITC and/or PE channels, HSCs were stained instead with Lin/PE-Cy5, Sca-1-PE-Cy7 (BioLegend, 108114), CD48-PB (BioLegend, 1103418), CD150-APC (BioLegend, 1115910), and Flk2-Bio followed by SA-PeCy7. For myeloid progenitor analyses in Gfp-Lc3 mice, cells were separately stained with Lin/PE-Cy5, c-Kit-APC-eFluor780, Sca-1-PB, Fcγ R-PerCPeFluor710, and CD34-Bio (BioLegend, 119304) followed by SA-Qdot605. For HSC chimaerism analyses, HSCs were stained with Lin/PE-Cy5, c-Kit-APC-eFluor780, Sca-1-PB, CD48-A647, CD150-PE, and Flk2-bio followed by SA-Qdot605, together with CD45.2-FITC (eBioscience, 11-0454-85) and CD45.1-PE-Cy7 (eBioscience, 25-0453-82). For mature cell analyses, unfractionated bone marrow cells were stained with Mac-1-PE-Cy7 (eBioscience, 25-0112-82), Gr-1-PB (eBioscience, 57-5931-82), B220-APC-Cy7 (eBioscience, 47-0452-82), CD19-PE (eBioscience, 12-0193-82), CD4-FITC (BD Biosciences, 553729), and CD8-PE (BioLegend, ARTICLE RESEARCH for 2-NBD glucose fluorescence in the FITC channel. For measurement of glucose uptake in GFP-LC3 HSCs, 6,000 HSCs were cultured with 100 μ M 2-deoxyglucose (2-DG) for 4 h and then processed according to the manufacturer's instructions (Glucose Uptake-Glo Assay, Promega, J1341). For BrdU incorporation assays, HSCs (1,000-2,000 cells) were directly sorted into 96-well plates, cultured for 3 h with 60 μ M BrdU (Sigma, B5002), and analysed by flow cytometry as described above. For measurement of nascent protein synthesis, HSCs were cultured with 20 μ M O-propargyl-puromycin (OP-puro, Thermo Fisher Scientific, C10457) for 30 min in + cyt media, processed according to the manufacturer's instructions, and analysed by immunofluorescence staining as described below. For replication stress assays, cells were cultured with the same cocktail of cytokines and aphidicolin (50 ng/ml, Sigma, A4487) in Iscove's modified Dulbecco's media (IMDM) supplemented with 5% FBS (StemCell Technology, 06200), 1× penicillin/streptomycin, 0.1 mM non-essential amino acids, 1 mM sodium pyruvate, 2 mM l-glutamine, and 50 μ M 2-mercaptoethanol. Immunofluorescence staining. HSCs (400-1,500 cells) were sorted directly onto poly-lysine coated slides (VWR International, P-4981) and fixed in PBS/4% PFA for 10 min at room temperature. Slides were permeabilized in PBS/0.15% Triton X-100 for 2 min at room temperature and blocked in PBS/1% BSA for 1 h at room temperature. Slides were then incubated in PBS/1% BSA with either rabbit antiFoxO3a (Millipore, 07-1719), mouse anti-phospho-H2AX (Ser139) (Millipore, 05-636), rabbit anti-53BP1 (Novus Biologicals, NB100-904), rabbit anti-FBL (Cell Signaling, 2639), mouse anti-RAD51 (Abcam, ab1837), mouse anti-LAMP1 (Developmental Studies Hybridoma Bank, 1D4B), mouse anti-KDEL (Abcam, ab12223), or rabbit anti-TOM20 (Santa Cruz Biotechnology, sc-11415) for 1 h at 37 °C. Slides were then washed three times in PBS and incubated for 1 h at 37 °C in PBS/1% BSA with appropriate secondary antibodies (all from Life Technologies): A488-conjugated goat anti-mouse (A-11029), A594-conjugated goat anti-rabbit (A-11037), A594-or A488-conjugated goat anti-rat (A-11007, A-10528), and A488-conjugated donkey anti-mouse (A-21202). Slides were finally washed three times in PBS and mounted using VectaShield (Vector Laboratories) containing 1 μ g/ml DAPI. EdU incorporation was detected using A594-labelled azide click chemistry according to the manufacturer's instructions (Life Technologies, Click-iT EdU imaging assay, C10339). For OP-puro analysis, after processing, slides were stained with anti-phospho-H2AX and then A488-conjugated goat anti-mouse. Cells were imaged on a SP5 Leica Upright Confocal Microscope (20× or 63× objective), and images were processed using Volocity software (version 4.4, Improvision, Waltham, Massachusetts, USA) and ImageJ. Between five and eight z-stacks were taken per image, and total fluorescence per cell was measured using Volocity on ≥ 20 cells per condition. In vitro assays. For western blot analyses, sorted HSCs (~ 30,000 cells per condition) were lysed in RIPA buffer, run on standard 12% SDS-PAGE gels, transferred onto nitrocellulose membranes (Bio-Rad, 162-0232), and blocked with 5% bovine serum albumin (BSA) in blocking buffer (Li-COR Biosciences, 927-40000) containing 0.1% Tween (BBT) for 1 h at room temperature according to standard protocols. Membranes were incubated for overnight at 4 °C in BBT with primary antibodies in BBT, washed once with BBT, incubated for 1 h at 4 °C in BBT with appropriate secondary antibodies, and detected on an Odyssey Infrared Imaging System (Li-COR Biosciences). Membranes were eventually stripped with NewBlot Stripping Buffer Nitro (Li-COR Biosciences, 928-40030) according to the manufacturer's instructions before being re-incubated with another primary antibody. Rabbit anti-phospho-AMPKα (Cell Signalling, 2535), rabbit anti-phospho-S6 (Cell Signalling, 2215), mouse anti-S6 (Cell Signalling, 2317), and rabbit antiactin (Sigma-Aldrich, A2066) were used as primary antibodies and IRDye 800CW Goat Anti-Rabbit IgG (Li-COR Biosciences, 926-32211) or IRDye 800CW Goat Anti-Mouse IgG (Li-COR Biosciences, 926-32210) as secondary antibodies. For Seahorse metabolic flux experiments, oxygen consumption rates and extracellular acidification rates were measured using a 96-well Seahorse Bioanalyzer XF 96 according to the manufacturer's instructions (Agilent Technologies). In brief, HSCs or LSK cells (75,000 cells per well) were sorted directly into 96-well plates precoated for 3 h with poly-lysine (Sigma-Aldrich, P4707) and containing cyt+ media. Plates were then centrifuged for 5 min at 1,200 r.p.m. and media was replaced with 175 μ l of temperature/CO 2 pre-adjusted + cyt media. Plates were either immediately analysed or cultured for 22 h before analysis according to the manufacturer's instructions with the following exceptions. For glycolysis assays, the starting + cyt media already contained glucose and 2 μ M oligoymycin followed by 1 M 2-DG was used. For OXPHOS assays, 1 μ M oligomycin followed by 2 μ M FCCP was used. For both assays, mix and read times were also extended to 7 min and 4 min, respectively. For electron microscopy analyses, cells (40,000-75,000 per condition) were pelleted for 5 min at 4 °C at 600g, fixed on ice for 30 min in 0.1 M NaCacodylate, pH 7.4, containing 2% glutaraldehyde and 1% PFA, and pelleted at 3,000g for 10 min at 4 °C. Samples were then submitted to the Gladstone Institutes (UCSF) Electron Microscopy Core Facility for standard transmission electron microscopy ultrastructural analyses. Mitochondria numbers and morphology were visually scored. For αKG measurements, 10 6 c-Kit-enriched bone marrow cells were processed according to the manufacturer's instructions (Biovision, K677-100). For SAM measurements, 15,000 HSCs were processed according to the manufacturer's instructions (Mediomics, 1-1-1004). Gene expression analyses. For microarray analyses, RNA was purified from sorted HSCs and GMPs (7,000-20,000 cells obtained from individual mice) using an Arcturus PicoPure RNA Isolation Kit, amplified using an Ovation Pico WTA System V2 (NuGEN, 3302-12), fragmented and biotinylated using the Encore Biotin Module (NuGEN, 4200-12) , and hybridized on Affymetrix Gene ST 1.0 microarrays according to the manufacturers' instructions. Transcriptome profiling was performed at the Gladstone Institutes Genomics Core (UCSF). Gene expression was first measured at the probe set level (n = 241,619) using robust multi-array average methodology followed by quantile normalization 37 . Quality of the data was assessed using principal component analysis as well as unsupervised hierarchical clustering. Probe set annotation for the MoGene1.0st version 1 array was downloaded from Affymetrix's website and the 241,619 probe sets were mapped to the 28,853 main transcript set (excluding controls). This data set was used for all analyses. We used a family of generalized, linear models implemented with the R package, LIMMA, to assess differential expression between groups of interest 38 .
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Nominal P values were corrected for multiple comparisons using a false discovery rate cutoff of 0.05. Gene set enrichment analyses were performed according to standard procedures on curated gene sets from previous publications. Normalized expression values for each replicate were used to generate an expression data set file, and gene set enrichment analyses was run using the weighted enrichment score. DAVID was used to functionally annotate the differentially expressed or methylated genes to Gene Ontology terms. For Fluidigm analyses, the Fluidigm 96.96 Dynamic Array integrated fluidic circuit was used and analyses were performed as previously described 36 . Briefly, HSCs or MPPs (100 cells per well) were directly sorted into 96-well plates containing CellsDirect lysis buffer (Invitrogen, 11753-100), reverse-transcribed and pre-amplified for 18 cycles using Superscript III Platinum Taq DNA polymerase (Invitrogen, 18080-044) with a custom-made set of 96 proprietary target-specific primers (Fluidigm). The resulting cDNAs were analysed on a Biomark system (Fluidigm) using EvaGreen Sybr dye (Bio-Rad, 172-5211). Data were collected with Biomark Data Collection Software (Fluidigm) and analysed using Biomark qPCR analysis software with a quality threshold of 0.65 and linear baseline correction. Melt curves and melting temperature (T m ) values for each assay reaction were checked individually, and reactions with melt curves showing multiple peaks or poor quality were discarded, leaving 69 genes for further analyses. For gene expression quantification, data were exported as a Microsoft Excel .csv file and analysed by the ΔΔ C t method using Actb normalization. Methylation analyses. DNA was isolated from sorted HSCs (4,000-24,000 cells obtained from individual mice) using an Allprep DNA/RNA Mini Kit (Qiagen, 80204) and used for library preparation. Enhanced reduced-representation bisulfite sequencing was performed as previously described 39 , except for gel size selection as only fragments of 150-450 bp were excised owing to the low input amount of starting DNA. Libraries were sequenced on an Illumina HiSeq 2500. Reads were aligned against a bisulfite-converted mouse genome (mm10) using Bowtie and Bismark (versions 2.2.6 and 0.14.5, respectively). After filtering and normalizing by coverage, differentially methylated cytosines were identified using MethylKit (version 0.9.4) and R statistical software (version 3.2.1) 40 . Significant DMRs were identified with eDMR (version 0.6.3.1) using the following parameters: ≥ 2 differentially methylated cytosines, ≥ 3 CpG, mean methylation difference ≥ 20, and DMR q value ≥ 0.05. DMRs were annotated to the RefSeq genes as previously described 41 . DAVID was used to functionally annotate the differentially methylated genes to Gene Ontology terms, SP_PIR_KEYWORDS, and KEGG Pathways with a false discovery rate cutoff of 0.1. ChIP-enrich was used to functionally annotate the differentially methylated genes to Gene Ontology terms and KEGG Pathways with a false discovery rate cutoff of 0.05. Maximum gene set size was limited to 500, and DMR were annotated to the nearest gene. Statistics. All experiments were repeated as indicated; n is the number of independent biological repeats. Numbers of independent experiments are reported in the Supplementary Information. Data are expressed as mean ± standard deviation (s.d.), or standard error of the mean (s.e.m.) as indicated when a group within an experiment had fewer than three independent repeats, and for all line graph visualization of results. Mice for transplantation were randomized, samples were alternated whenever possible, and no blinding protocol was used. No statistical method was used to predetermine sample size. P values were generated using twotailed Student's t-test, and were considered significant when ≤ 0.05. All experiments were repeated as indicated; n is the number of independent biological repeats that
